LEPTIN: BIOLOGICAL AND PATHOPHYSIOLOGICAL EFFECTS
- 作者: Pashentseva A.1, Verbovoy A.1, Kosareva O.1
-
隶属关系:
- 期: 卷 27, 编号 9 (2016)
- 页面: 10-13
- 栏目: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/116616
- ID: 116616
如何引用文章
详细
The paper shows the most important biological effects of leptin, its role in the pathogenesis of insulin resistance and type 2 diabetes mellitus, and its effect on the development of cardiovascular diseases.
全文:
作者简介
A. Pashentseva
Email: a-pashentseva@yandex.ru
Candidate of Medical Sciences Samara State Medical University
A. Verbovoy
Professor MD Samara State Medical University
O. Kosareva
Candidate of Medical Sciences Samara State Medical University
参考
- Yuan Т., Zhao W., et al. Association between four adipocins and insulin sensitivity in patients with obesity, type 1 or type 2 diabetes mellitus, and in the general Chinese population // Clin. Med. J. - 2010; 123 (15): 2018-22.
- Hirsch J., Frield S., Edens N. et al. The fat cell // Med. Clin. North. Amer. -1989; 73: 83-95.
- Friedman М., Halaas J. Leptin and the regulation of body weight in mammals // Nature. - 1998; 395 (6704): 763-70.
- Van Harmelen V., Reynisdottir S., Eriksson P. et al. Leptin secretion from subcutaneous and visceral adipose tissue in women // Diabetes. - 1998; 47: 913-7.
- Saad M., Riad-Gabriel M., KhunA. et al. Diurnal and ultradian rhythmicity of plasma leptin: effects of gender and adiposity // J. Clin. Endocrin. Metab. - 1998; 83: 453-9.
- Vuagnat В., Pierroz D., Lalaoui M. et al. Evidence for a leptin- neuropeptide Y axis for the regulation of growth hormone secretion in the rat // Neuroendocrinology. - 1998; 67: 291-300.
- Halaas J., Gajiwala K., Maffey М. et al. Weight-reducing effects of the plasma protein encoded by the obese gene // Science. - 1995; 269: 543-6.
- Stephens T., Basinski М., Bristow P. et al. The role of neuropeptide Y in the antiobesity action of the obese gene product // Nature. - 1995; 377: 530-2.
- Cusin I., Rohner-Jeanrenaud F., Stricker-Krongrad A. et al. The weight-reducing effect of an intracerebro-ventricular bolus injection of leptin in genetically obese fa/fa rats // Diabetes. - 1996; 45: 1446-50.
- Shigemura N., Ohta R., Kusakabe Y. et al. Leptin modulates behavioral responses to sweet substances by influencing peripheral taste structures // Endocrin. - 2004; 145: 839-47.
- De Luca C., Kowalski T., Zhang Y. et al. Complete rescue of obesity, diabetes, and infertility in db/db mice by neuron-specific LEPR-B transgenes // J. Clin. Invest. - 2005; 115 (12): 3484-93.
- Mauro L., Catalano S., Bossi G. et al. Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression // Cancer Res. - 2007; 67 (7): 3412-21.
- Spiegelman B., Flier J. Adipogenesis and obesity: rounding out the big picture // Cell. - 1996; 87: 377-89.
- Bjorbaek C., Kahn B. Leptin signaling in the central nervous system and the periphery // Recent Prog. Horm. Res. - 2004; 59: 305-31.
- Flier J. Obesity wars: molecular progress confronts an expanding epidemic // Cell. - 2004; 116: 337-50.
- Saad M., Khan A., Sharma A. et al. Physiological insulinemia acutely modulates plasma leptin // Diabetes. - 1998; 47: 544-9.
- Utriainen T., Malmstrom R., Makimattila S. et al. Supraphysiological hyperinsulinemia increases plasma leptin concentrations after 4 h in normal subjects // Diabetes. - 1996; 45: 1364-6.
- Saladin R., De Vos P., Guerre-Millo M. et al. Transient increase in obese gene expression after food intake or insulin administration // Nature. - 1995; 377: 527-9.
- D'Adamo M., Buongiomo E., Maroccia F. et al. Increased OB gene expression leads to elevated plasma leptin concentrations in patients with chronic primary hyperinsulinemia // Diabetes. - 1998; 47: 1625-9.
- Kieffer T., Habener J. The adipoinsular axis: effects of leptin on pancreatic b-cells // Am. J. Physiol. - 2000; 278: 1-14.
- Larsson H., Elmstahl S., Ahren B. Plasma leptin levels correlate to islet function independently of body fat in postmenopausal women // Diabetes. - 1996; 45 (11): 1580-4.
- Haffner S., Miettinen K., Mykkanen I. et al. Leptin concentrations are associated with higher proinsulin and insulin concentrations but a lower proinsulin / insulin ratio in non-diabetic subjects // Int. J. Obes. - 1998; 22: 899-905.
- Widjaja A., Stratton I., Horn R. et al. UKPDS 20: plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects // J. Clin. Endocrinol. Metab. - 1997; 82 (2): 654-7.
- Muoio D., Dohm G., Tapscott E. et al. Leptin opposes insulin's effects on fatty acid partitioning in muscle isolated from obese ob ob mice // Am. J. Physiol. - 1999; 276: 913-21.
- Lord G., Matarese G., Howard J. Leptin modulates the T-cell immune response and reverses starvation- induced immunosuppression // Nature. - 1998; 394: 897-901
- Margetic S., Gazzola C., Pegg G. et al. Leptin: a review of its peripheral actions and interactions // Int. J. Obes. Relat. Metab. Disord. - 2002; 26: 407-1433.
- Cock T., Auwerx J. Leptin: cutting the fat off the bone // Lancet. - 2003; 362: 1572-4.
- Будылина М.В. Взаимоотношения лептина с физическим и половым развитием мальчиков в пубертатном периоде. Автореф. дис.. канд. мед. наук. Ижевск, 2005; 21 с.
- Кожевникова А.А. Взаимоотношения лептина с физическим и половым развитием девочек в пубертатном периоде. Автореф. дис.. канд. мед. наук. Казань, 2006; 23 с.
- Пашенцева A.B., Скудаева E.C., Вербовой А.Ф. Лептин, резистин и инсулинорезистентность у пациентов с сахарным диабетом 2 типа // Терапевт. - 2011; 5: 4-8.
- Вербовой А.Ф., Ворожцова Е.И., Орлова Т.Н. Метаболические показатели у мужчин с сахарным диабетом 2 типа и ишемической болезнью сердца // Фарматека. - 2012; 9: 60-4.
- Вербовой А.Ф., Соломонова Е.С., Пашенцева А.В. Лептин, резистин и оментин у пациентов с нарушенной толерантностью к глюкозе и сахарным диабетом 2 типа // Известия вузов. Поволжский регион. Медицинские науки. - 2012; 3: 52-7.
- Вербовой А.Ф., Вербовая Н.И., Капралова И.Ю. Адипонектин, лептин и другие метаболические показатели у больных гипотиреозом // Фарматека. -2014; 10: 67-9.
- Косарева О.В., Вербовой А.Ф., Шаронова Л.А. Оценка взаимосвязи адипокинов и параметров углеводного и жирового обменов у больных акромегалией // Эндокринология: новости, мнения обучение. - 2013; 1 (25): 54-7.
- Lembo G., Vecchione C., Fratta L. et al. Leptin induces direct vasodilation through distinct endothelial mechanisms // Diabetes. - 2000; 49 (2): 293-7.
- Hercule H., Schunck W., Gross V. et al. Interaction between P450 eicosanoids and nitric oxide in the control of arterial tone in mice // Arterioscler. Thromb. Vasa Biol. - 2009; 29 (1): 54-60.
- Fortuno A., Rodriguez A., Gomez-Ambrosi J. et al. Leptin inhibits angiotensin Il-induced intracellular calcium increase and vasoconstriction in the rat aorta // Endocrinology. - 2002; 143 (9): 3555-60.
- Фомина И.А. Взаимосвязь лептина и метаболических показателей при пубертатно-юношеском диспитуитаризме у юношей. Автореф. дис.. канд. мед. наук. Самара, 2009; 25 с.
- Fruhbeck G. Pivotal role of nitric oxide in the control of blood pressure after leptin administration // Diabetes. - 1999; 48 (4): 903-8.
- Shankar A., Xiao J. Positive relationship between plasma leptin level and hypertension // Hypertension. - 2010; 56 (4): 623-8.
- Korda M., Kubant R., Patton S. et al. Leptin-induced endothelial dysfunction in obesity // Am. J. Physiol. Heart Circ. Physiol. - 2008; 295: 1514-21.
- Zeidan A., Purdham D., Rajapurohitam V. et al. Leptin induces vascular smooth muscle cell hypertrophy through angiotensin II- and endothelin-1-dependent mechanisms and mediates stretch- induced hypertrophy // J. Pharmacol. Exp. Ther. - 2005; 315: 1075-84.
- Loffreda S., Yang S., Lin H. et al. Leptin regulates proinflammatory immune responses // FASEB J. - 1998; 12: 57-65.
- Zeidan A., Purdham D., Rajapurohitam V. et al. Leptin induces vascular smooth muscle cell hypertrophy through angiotensin II - and endothelin-1-dependent mechanisms and mediates stretch-incluced hypertrophy // J. Pharmacol. Exp. Ther. - 2005; 315 (3): 1075-85.
- Karaduman M., Oktenli C. Musabak U. et al. Leptin, soluble interleikin-6 receptor, C - reactive protein and soluble vascular cell adhesion molecule-1 levels in human coronary atheroscloretic plague // Clin. Exp. Immunol. - 2006; 143 (3): 452-7.
- Singh P., Hoffmann M., Wolk R. et al. Leptin induces C-reactive protein expression in vascular endothelial cells // Arterioscler. Thromb. Vasc. Biol. - 2007; 27 (9): 302-7.
- Singh P., Peterson Т., Barber K. et al. Leptin upregulates the expression of plasminogen activator inhibitor-1 in human vascular endothelial cells // Biochem. Biophys. Res. Com. - 2010; 392 (1): 47-52.
- Sobel B., Taatjes D., Schneider D. Intramural plasminogen activator inhibitortype-1 and coronary atherosclerosis // Arterioscler. Thromb. Vasc. Biol. -2003; 23 (11): 1979-89.
- Волов Н.А., Адамов П.Б., Лебедева А.Ю. и др. Лептин - новый фактор риска сердечно-сосудистых заболеваний // Терапевт. - 2011; 8: 50-4.
- Sierra-Johnson J. et al. Relation of increased leptin concentrations to history of myocardial infarction and stroke in the United State population // Am. J. Cardiol. - 2007; 100: 234-9.